ACRVVSMRNA• 3 Months (Normalized)
ACRV vs MRNA (Acrivon Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
+8.28%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $145.62
+127.67%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-119.39%
MRNA outperforming by 119.39%
ACRVMRNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ACRV Price | ACRV Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | +8.28% | $145.62 | +127.67% | -119.39% |
| Sep 15, 2026 | $1.83 | +16.56% | $143.77 | +124.78% | -108.22% |
| Sep 14, 2026 | $1.96 | +24.84% | $146.69 | +129.35% | -104.51% |
| Sep 11, 2026 | $2.00 | +27.39% | $143.97 | +125.09% | -97.70% |
| Sep 10, 2026 | $2.04 | +29.94% | $136.62 | +113.60% | -83.66% |
| Sep 09, 2026 | $1.99 | +26.75% | $135.61 | +112.02% | -85.27% |
| Sep 08, 2026 | $2.10 | +33.76% | $140.33 | +119.40% | -85.64% |
| Sep 04, 2026 | $2.13 | +35.67% | $145.55 | +127.56% | -91.89% |
| Sep 03, 2026 | $2.06 | +31.21% | $148.87 | +132.75% | -101.54% |
| Sep 02, 2026 | $2.15 | +36.94% | $150.81 | +135.79% | -98.85% |
| Sep 01, 2026 | $2.07 | +31.85% | $154.27 | +141.20% | -109.35% |
| Aug 31, 2026 | $2.09 | +33.12% | $140.34 | +119.42% | -86.30% |
| Aug 28, 2026 | $2.06 | +31.21% | $137.99 | +115.74% | -84.53% |
| Aug 27, 2026 | $2.15 | +36.94% | $142.77 | +123.22% | -86.28% |
| Aug 26, 2026 | $2.08 | +32.48% | $149.66 | +133.99% | -101.51% |
Page 1 of 5